Label: ENGYSTOL- cynanchum vincetoxicum root and sulfur injection

  • NDC Code(s): 50114-7015-1, 50114-7015-2
  • Packager: MediNatura
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved homeopathic

DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Drug Label Information

Updated October 14, 2021

If you are a consumer or patient please visit this version.

  • DESCRIPTION

    Ingredient name

    Potency

    Quantity

    Final dilution

    Asclepias vincetoxicum

    6X

    6.6 μl

    8.22X

    Asclepias vincetoxicum

    10X

    6.6 μl

    12.22X

    Asclepias vincetoxicum

    30X

    6.6 μl

    32.22X

    Sulphur

    4X

    3.3 μl

    6.52X

    Sulphur

    10X

    3.3 μl

    12.52X

  • INDICATIONS AND USAGE

    Engystol® Injection Solution is a homeopathic drug product indicated for the support of the immune system to reduce severity and duration of symptoms in viral infections, particularly in the early stages of colds and influenza-like illnesses.

  • DOSAGE AND ADMINISTRATION

    General Considerations

    • The dosage schedules listed below can be used as a general guide for the administration of Engystol® Injection Solution.

    • Engystol® Injection Solution may be administered s.c., i.d., i.m., or i.v.

    • The interval between injections is left to the discretion of the HCP, but should not exceed 1 ampule in 24 hours.

    • Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Discard any unused ampule contents.

    • Draw up required dose into syringe.

    • Discard any unused ampule contents. Do not reuse ampule.

    • Only licensed practitioners with sufficient expertise in injecting drugs, including the respective route of administration, should administer the product.

    Standard Dosage:

    Adults and children 12 years and older: 1 ml 1 to 3 times per 7 days.

    Children 6 to 11 years: 0.7 ml 1 to 3 times per 7 days.

    Children 2 to 5 years: 0.5 ml 1 to 3 times per 7 days.

    Acute Dosage:

    Adults and children 12 years and older: 1 ml daily, and then continue with standard dosage.

    Children 6 to 11 years: 0.7 ml daily, and then continue with standard dosage.

    Children 2 to 5 years: 0.5 ml daily, and then continue with standard dosage.

  • CONTRAINDICATIONS

    Engystol® Injection Solution is contraindicated in patients with known hypersensitivity to Engystol® or any of its ingredients.

  • WARNINGS AND PRECAUTIONS

    None

  • ADVERSE REACTIONS

    Post-marketing Experience

    • The following adverse events have been identified during post-marketing use of Engystol® Injection Solution. Because these events are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

    • Allergic (hypersensitivity) skin reactions may occur in isolated cases.

    To report SUSPECTED ADVERSE REACTIONS, contact MediNatura. at 1.844.633.4628 or info@medinatura.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

  • OVERDOSAGE

    No negative effects of an overdose have been reported and none are expected due to the homeopathic dilutions.

  • CLINICAL PHARMACOLOGY

    Mechanism of Action

    The exact mechanism of Engystol® Injection Solution is not fully understood.

    Pharmacodynamics

    Not applicable for homeopathic medicinal products.

  • DOSAGE

    1 ampule containing 1.1 ml solution for injection each containing the active ingredients in the strengths listed under Description.

  • PRINCIPAL DISPLAY PANEL

    Engystol 1.1ml Injection.jpg

  • INGREDIENTS AND APPEARANCE
    ENGYSTOL 
    cynanchum vincetoxicum root and sulfur injection
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:50114-7015
    Route of AdministrationINTRADERMAL, INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CYNANCHUM VINCETOXICUM ROOT (UNII: 9R858U917W) (CYNANCHUM VINCETOXICUM ROOT - UNII:9R858U917W) CYNANCHUM VINCETOXICUM ROOT6 [hp_X]  in 1.1 mL
    SULFUR (UNII: 70FD1KFU70) (SULFUR - UNII:70FD1KFU70) SULFUR4 [hp_X]  in 1.1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:50114-7015-110 in 1 CARTON05/31/201402/28/2025
    11.1 mL in 1 AMPULE; Type 0: Not a Combination Product
    2NDC:50114-7015-23 in 1 CARTON05/31/201402/28/2025
    21.1 mL in 1 AMPULE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved homeopathic05/31/201402/28/2025
    Labeler - MediNatura (102783016)
    Establishment
    NameAddressID/FEIBusiness Operations
    Hameln Pharma GmbH315869123manufacture(50114-7015)
    Establishment
    NameAddressID/FEIBusiness Operations
    Biologische Heilmittel Heel315635359manufacture(50114-7015)